Genetic and biochemical markers for Alzheimer's disease: recent developments.
Mulder
C
C
Department of Clinical Chemistry, University Hospital Vrije Universiteit, Amsterdam, The Netherlands.
Scheltens
P
P
Visser
J J
JJ
van Kamp
G J
GJ
Schutgens
R B
RB
D000544:Alzheimer Disease / Q000175:diagnosis* / Q000209:etiology / Q000235:genetics / Q000378:metabolism; D016229:Amyloid beta-Peptides / Q000134:cerebrospinal fluid; D016564:Amyloid beta-Protein Precursor / Q000235:genetics / Q000378:metabolism; D001057:Apolipoproteins E / Q000235:genetics / Q000378:metabolism; D015415:Biomarkers; D001923:Brain Chemistry; D002556:Cerebrospinal Fluid Proteins / Q000032:analysis / Q000235:genetics; D003937:Diagnosis, Differential; D006801:Humans; D009154:Mutation; D011506:Proteins / Q000235:genetics / Q000378:metabolism; D012680:Sensitivity and Specificity; D016875:tau Proteins / Q000134:cerebrospinal fluid / Q000235:genetics / Q000378:metabolism
D016229:Amyloid beta-Peptides; D016564:Amyloid beta-Protein Precursor; D001057:Apolipoproteins E; D015415:Biomarkers; D002556:Cerebrospinal Fluid Proteins; D011506:Proteins; D016875:tau Proteins